Explore Our Comprehensive Life Sciences Industry Research Reports
P
2021
The Asia-Pacific nuclear medicine market size was valued at $4,116.43 million in 2020, and is projected to reach $8,957.89 million by 2028, registering a CAGR of 10.4% from 2021 to 2028.
Report Code : A01062 | Pages : 142 | Category : Life Sciences
U
2024
Alzheimer’s is a neurodegenerative disorder that mostly occurs with aging and is a leading cause of dementia. The global Alzheimer’s disease market has observed tremendous growth in the ...
Report Code : A01122 | Category : Life Sciences
P
2021
The global infectious disease diagnostic market was valued at $23,321.99 million in 2020, and is estimated to reach $39,941.37 million by 2030, growing at a CAGR of 6.8% ...
Report Code : A01681 | Pages : 257 | Category : Life Sciences
U
2024
Autoimmune diseases refer to a body™s abnormal immune response leading to production of antibodies that attack own cells and tissues, causing deterioration and destruction of healthy tissues. There ...
Report Code : A02365 | Category : Life Sciences
P
2020
The Europe in vitro diagnostics market (IVD) was valued at $13,825 million in 2019, and is projected to reach $18,647 million at a CAGR of 4.8% from 2020 to 2027.
Report Code : A04004 | Pages : 289 | Category : Life Sciences
U
2024
Lyme disease is a bacterial infection caused by species borrelia. It generally spreads in the humans through infected ticks bite. Patients infected with Lyme disease suffer from symptoms ...
Report Code : A04061 | Category : Life Sciences
U
2024
According to the World Health Organization (WHO), respiratory infectious diseases are the third leading cause of death and result in over all three million deaths per year across ...
Report Code : A04149 | Category : Life Sciences
P
2020
The global veterinary infectious disease diagnostics market was valued at $1,271 million in 2018, and is expected to reach $2,404 million by 2026, registering a CAGR of 8.3% from 2019 to 2026.
Report Code : A06097 | Pages : 206 | Category : Life Sciences
P
2022
The global liver disease diagnostics market was valued at $34.5 billion in 2021, and is projected to reach $62.6 billion by 2031, growing at a CAGR of 6.1% from 2022 to 2031.
Report Code : A08425 | Pages : 203 | Category : Life Sciences
A
2024
Report Overview
The report covers exhaustive analysis of global Phytopathological ...
Report Code : A111771 | Category : Life Sciences
Register and Earn 500 Loyalty Points
An Email Verification Code has been sent to your email address!
Please check your inbox and, if you don't find it there, also look in your junk folder.